UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 728

Sortiert nach

Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones

Journal of medicinal chemistry, 1987-12, Vol.30 (12), p.2277-2283

1987

Volltextzugriff (PDF)

Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-Imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents

Journal of medicinal chemistry, 1986-05, Vol.29 (5), p.816-819

1986

Volltextzugriff (PDF)

Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides

Journal of medicinal chemistry, 1986-04, Vol.29 (4), p.523-530

1986

Volltextzugriff (PDF)

Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitors

Journal of medicinal chemistry, 1987-06, Vol.30 (6), p.1036-1040

1987

Volltextzugriff (PDF)

Derivatives of 1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione as anxiolytic agents

Journal of medicinal chemistry, 1978-10, Vol.21 (10), p.1087-1089

1978

Volltextzugriff (PDF)

Derivatives of 11-(1-piperazinyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine as central nervous system agents

Journal of medicinal chemistry, 1980-04, Vol.23 (4), p.462-465

1980

Volltextzugriff (PDF)

Azacyclonal in mental deficiency practice: a preliminary report

Journal of mental science, 1958-04, Vol.104 (435), p.485-487

WRIGHT, W B

1958

Volltextzugriff (PDF)

Central nervous system depressants. IV. 2-aminoalkyl-1,2-dihydro-3H-imidazo(1,5-a)indol-3-ones

Journal of medicinal chemistry, 1968-11, Vol.11 (6), p.1164-1167

1968

Volltextzugriff (PDF)

Solitary plasmacytoma of the skull

Confinia neurologica, 1953, Vol.13 (1), p.6

WRIGHT, W B

1953

Volltextzugriff (PDF)

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-06, Vol.315 (24), p.2673

2016

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-10, Vol.34 (28), p.3460-3473

2016

Volltextzugriff (PDF)

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2017-08, Vol.377 (8), p.745-755

2017

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Gynecologic oncology, 2016-10, Vol.143 (1), p.3-15

2016

Volltextzugriff (PDF)

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

The New England journal of medicine, 2024-01, Vol.390 (2), p.107-117

2024

Volltextzugriff (PDF)

Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury

Journal of neurotrauma, 2012-05, Vol.29 (8), p.1614

2012

Volltextzugriff (PDF)

A platform for the discovery of new macrolide antibiotics

Nature (London), 2016-05, Vol.533 (7603), p.338-345

2016

Volltextzugriff (PDF)

Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications

Stem cells (Dayton, Ohio), 2011-02, Vol.29 (2), p.169-178

2011

Volltextzugriff (PDF)

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial

The journals of gerontology. Series A, Biological sciences and medical sciences, 2016-05, Vol.71 (5), p.649-655

2016

Volltextzugriff (PDF)

Assessing the generality of global leaf trait relationships

The New phytologist, 2005-05, Vol.166 (2), p.485-496

2005

Volltextzugriff (PDF)

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

Nature communications, 2021-11, Vol.12 (1), p.6468-20, Article 6468

2021

Volltextzugriff (PDF)

Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT

Hypertension (Dallas, Tex. 1979), 2020-03, Vol.75 (3), p.660-667

2020

Volltextzugriff (PDF)

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)

American journal of kidney diseases, 2017-09, Vol.70 (3), p.357-367

2017

Volltextzugriff (PDF)

Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial

JAMA neurology, 2022-04, Vol.79 (4), p.380

2022

Volltextzugriff (PDF)

1 – 25 von 728

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(699)
Mit Volltextzugriff
(573)

Publikationsform

Artikel
(728)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones

Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-Imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents

Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides

Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitors

Derivatives of 1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione as anxiolytic agents

Derivatives of 11-(1-piperazinyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine as central nervous system agents

Azacyclonal in mental deficiency practice: a preliminary report

Central nervous system depressants. IV. 2-aminoalkyl-1,2-dihydro-3H-imidazo(1,5-a)indol-3-ones

Solitary plasmacytoma of the skull

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury

A platform for the discovery of new macrolide antibiotics

Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes

Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial

Assessing the generality of global leaf trait relationships

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)

Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial

Aktive Filter

Suchergebnisse filtern